Agreement signedPublished 31 Jul 2023

Sumitomo Pharma Co., Ltd. /
Nabriva Therapeutics plc

Sumitomo Pharma Co., Ltd. agrees to buy Nabriva Therapeutics plc

Buy side: Sumitomo Pharma Co., Ltd.
Buy sideSumitomo Pharma Co., Ltd.
Target: Nabriva Therapeutics plc
TargetNabriva Therapeutics plc
Source · 31 Jul 2023
Buy side: Sumitomo Pharma Co., Ltd.
Buy sideSumitomo Pharma Co., Ltd.
Target: Nabriva Therapeutics plc
TargetNabriva Therapeutics plc
01 / BuyerSumitomo Pharma Co., Ltd.
02 / TargetNabriva Therapeutics plc
01

What happened

Sumitomo Pharma Co., Ltd. agreed to acquire Nabriva Therapeutics plc, according to a filing dated July 31, 2023.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Sumitomo Pharma Co., Ltd. agrees to buy Nabriva Therapeutics plc

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.